{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:17:35Z","timestamp":1792682255596,"version":"4.5.0"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,4,15]]},"DOI":"10.2169\/internalmedicine.0145-22","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T22:13:18Z","timestamp":1663020798000},"page":"1185-1189","source":"Crossref","is-referenced-by-count":10,"title":["Lacosamide Intoxication-induced Wide QRS Tachycardia Successfully Treated with Veno-arterial Extracorporeal Membrane Oxygenation"],"prefix":"10.2169","volume":"62","author":[{"given":"Chihiro","family":"Takai","sequence":"first","affiliation":[{"name":"Department of Emergency and Critical Care, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Misumi","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Saiseikai Utsunomiya Hospital, Japan"},{"name":"Department of Cardiology, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Kaito","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Yoshii","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Koinuma","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kadoya","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Saiseikai Utsunomiya Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Husain A, Chung S, Faught E, Isojarvi J, McShea C, Doty P. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a phase III open-label extension trial. Epilepsia 53: 521-528, 2012.","DOI":"10.1111\/j.1528-1167.2012.03407.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Beyreuther BK, Freitag J, Heers C, Krebsf\u00e4nger N, Scharfenecker U, St\u00f6hr T. Lacosamide: A review of preclinical properties. CNS Drug Rev 13: 21-42, 2007.","DOI":"10.1111\/j.1527-3458.2007.00001.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Schultz L, Mahmoud SH. Is therapeutic drug monitoring of lacosamide needed in patients with seizures and epilepsy? Eur J Drug Metab Pharmacokinet 45: 315-349, 2020.","DOI":"10.1007\/s13318-019-00601-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hou L, Peng B, Zhang D, et al. Clinical efficacy and safety of lacosamide as an adjunctive treatment in adults with refractory epilepsy. Front Neurol 12: 712717, 2021.","DOI":"10.3389\/fneur.2021.712717"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yadav R, Schrem E, Yadav V, Jayarangaiah A, Das S, Theetha Kariyanna P. Lacosamide-related arrhythmias: a systematic analysis and review of the literature. Cureus 13: e20736, 2021.","DOI":"10.7759\/cureus.20736"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Eleftheriou G, Butera R, Gallo M, et al. Lacosamide-induced recurrent ventricular fibrillation: a case report. Int J Clin Pharmacol Ther 58: 736-739, 2020.","DOI":"10.5414\/CP203813"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chua-Tuan JL, Cao D, Iwanicki JL, Hoyte CO. Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: case report. Clin Toxicol 53: 565-568, 2015.","DOI":"10.3109\/15563650.2015.1040157"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest. Circ Heart Fail 11: e004905, 2018.","DOI":"10.1161\/CIRCHEARTFAILURE.118.004905"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shekar K, Mullany DV, Thomson B, Ziegenfuss M, Platts DG, Fraser JF. Extracorporeal life support devices and strategies for management of acute cardiorespiratory failure in adult patients: a comprehensive review. Crit Care 18: 219, 2014.","DOI":"10.1186\/cc13865"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Alsdorf R, Wyszynski DF. Teratogenicity of sodium valproate. Expert Opin Drug Saf 4: 345-353, 2005.","DOI":"10.1517\/14740338.4.2.345"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. DeGiorgio CM. Atrial flutter\/atrial fibrillation associated with lacosamide for partial seizures. Epilepsy Beha 18: 322-324, 2010.","DOI":"10.1016\/j.yebeh.2010.04.043"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Krause LU, Brodowski KO, Kellinghaus C. Atrioventricular block following lacosamide intoxication. Epilepsy Behav 20: 725-727, 2011.","DOI":"10.1016\/j.yebeh.2011.02.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Malissin I, Baud FJ, Deveaux M, Champion S, Deye N, Megarbane B. Fatal lacosamide poisoning in relation to cardiac conduction impairment and cardiovascular failure. Clin Toxicol 51: 381-382, 2013.","DOI":"10.3109\/15563650.2013.778993"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nizam A, Mylavarapu K, Thomas D, et al. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy. Epilepsia 52: e153-e155, 2011.","DOI":"10.1111\/j.1528-1167.2011.03212.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shaibani A, Fares S, Selam JL, et al. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. J Pain 10: 818-828, 2009.","DOI":"10.1016\/j.jpain.2009.01.322"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chinnasami S, Rathore C, Duncan JS. Sinus node dysfunction: an adverse effect of lacosamide. Epilepsia 54: 90-93, 2013.","DOI":"10.1111\/epi.12108"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Brugada P, Brugada J, Mont L, Smeets J, Andries EW. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 83: 1649-1659, 1991.","DOI":"10.1161\/01.CIR.83.5.1649"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tisdale JE, Chung MK, Campbell KB, et al. Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation 142: e214-e233, 2020.","DOI":"10.1161\/CIR.0000000000000905"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pineton De Chambrun M, Br\u00e9chot N, Combes A. Venoarterial extracorporeal membrane oxygenation in cardiogenic shock: indications, mode of operation, and current evidence. Curr Opin Crit Care 25: 397-402, 2019.","DOI":"10.1097\/MCC.0000000000000627"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Chen YS, Lin JW, Yu HY, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 372: 554-561, 2008.","DOI":"10.1016\/S0140-6736(08)60958-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rona R, Cortinovis B, Marcolin R, et al. Extra-corporeal life support for near-fatal multi-drug intoxication: a case report. J Med Case Rep 5: 1-5, 2011.","DOI":"10.1186\/1752-1947-5-231"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bilbault P, Pynn S, Mathien C, Mazzucotelli JP, Schneider F, Jaeger A. Near-fatal betaxolol self-poisoning treated with percutaneous extracorporeal life support. Eur J Emerg Med 14: 120-122, 2007.","DOI":"10.1097\/MEJ.0b013e328013f87c"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cawello W, Fuhr U, Hering U, Maatouk H, Halabi A. Impact of impaired renal function on the pharmacokinetics of the antiepileptic drug lacosamide. Clin Pharmacokinet 52: 897-906, 2013.","DOI":"10.1007\/s40262-013-0080-7"},{"key":"24","unstructured":"24. Ozdemir O, Soylu M, Duran Demir A, et al. Increased sympathetic nervous system activity: as cause of exercise-induced ventricular tachycardia in patients with normal coronary arteries. Texas Heart Inst J 30: 100-104, 2003."},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Dusi V, De Ferrari GM. The sympathetic nervous system and arrhythmogenic right ventricular cardiomyopathy: further evidence of a strong tie. Heart Rhythm 16: 1011-1012, 2019.","DOI":"10.1016\/j.hrthm.2019.02.004"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/8\/62_0145-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:55Z","timestamp":1715315515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/8\/62_0145-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,15]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0145-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,15]]},"article-number":"0145-22"}}